Tadalafil: Protective Action against the Development of Multiple Organ Failure Syndrome.

Oliveira, Granville G de; Oliveira, Samer A H de; Botelho, Paulo Henrique H; Oliveira, Marcos Aurelio Barboza de; Bian, Ka; Murad, Ferid

Oliveira, Granville G de; Oliveira, Samer A H de; Botelho, Paulo Henrique H; Oliveira, Marcos Aurelio Barboza de; Bian, Ka; Murad, Ferid.

Affiliation

Oliveira GG; Universidade Católica de Brasília (UCB), Brasília, DF, Brazil.
Oliveira SAH; Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, SP, Brazil.
Botelho PHH; George Washington School of Medicine and Health Sciences, Washington, DC, USA.
Oliveira MAB; University Hospitals Case Medical Center, Department of Cardiology, Division of Electrophysiology, Cleveland, OH, USA.
Bian K; Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, SP, Brazil.
Murad F; Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, SP, Brazil.

Braz J Cardiovasc Surg ; 32(4): 312-317, 2017.

Article de En | MEDLINE | ID: mdl-28977204

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Agents protecteurs / Inhibiteurs de la phosphodiestérase-5 / Tadalafil / Défaillance multiviscérale Type d'étude: Etiology_studies / Guideline / Prognostic_studies Limites: Animals Langue: En Journal: Braz J Cardiovasc Surg Sujet du journal: ANGIOLOGIA / CARDIOLOGIA Année: 2017 Type de document: Article Pays d'affiliation: Brésil

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google